Literature DB >> 20016187

Fertility-sparing approach in a teenager with uterine tumor diagnosed as a sarcoma on imaging.

Paul Berveiller1, Olivier Mir, Yves Menu, Maryam Jamali, Bruno Carbonne.   

Abstract

BACKGROUND: Uterine tumors are extremely rare in teenage patients. Although magnetic resonance imaging (MRI) can help distinguish between leiomyoma and sarcoma, it may also seriously mislead the diagnosis. CASE REPORT: An 18-year-old female patient presented with marked anemia, and a rapidly growing uterine tumor that strongly suggested uterine sarcoma on MRI. In order to avoid dispensable radical surgery, explorative laparotomy with tumor biopsy was performed after balancing risk/benefit ratio. Extemporaneous pathologic examination revealed a benign leiomyoma, and the patient subsequently underwent complete conservative myomectomy.
CONCLUSION: Preserving fertility is an important issue in young patients with uterine tumors, and tumor biopsy may overcome MRI false positive results, as illustrated in this case. Conservative approach deserves further evaluation in this specific setting. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2009        PMID: 20016187     DOI: 10.1159/000264681

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  3 in total

Review 1.  Uterine leiomyoma in a 19-year-old girl: Case report and literature review.

Authors:  A Ernest; A Mwakalebela; B C Mpondo
Journal:  Malawi Med J       Date:  2016-03       Impact factor: 0.875

2.  Fibromatous uterus in a 16-year-old girl: a case report.

Authors:  Athina C Tsili; Ekaterini D Lentoudi; Maria I Argyropoulou; Nikolaos Dalkalitsis; Anna Batistatou; Evangelos Paraskevaidis; Konstantine Tsampoulas
Journal:  Case Rep Med       Date:  2010-11-28

3.  Fertility-Sparing Management May Be Considered in Young Women with Uterine Sarcoma.

Authors:  Szymon Piątek; Iwona Szymusik; Anna Dańska-Bidzińska; Mariusz Ołtarzewski; Gabriela Trojan; Mariusz Bidziński
Journal:  J Clin Med       Date:  2022-08-15       Impact factor: 4.964

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.